Medigus Ltd.
Symbol: MDGS
NASDAQ
2.745
USDMarktpreis heute
-0.2062
P/E-Verhältnis
-0.0022
PEG-Verhältnis
4.67M
MRK Kapital
- 0.00%
DIV Rendite
Medigus Ltd. (MDGS) Finanzberichte
Bilanz
common:word.in-mln USD Growth | TTM | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
balance-sheet.row.cash-and-short-term-investments | 79.33 | 25.1 | 27.3 | 22.4 | ||||||||||
balance-sheet.row.short-term-investments | 8.11 | 5 | 3.3 | 0 | ||||||||||
balance-sheet.row.net-receivables | 94.87 | 25.2 | 1.7 | 0.3 | ||||||||||
balance-sheet.row.inventory | 8.67 | 1.8 | 1.2 | 0.2 | ||||||||||
balance-sheet.row.other-current-assets | 21.11 | 0.2 | 0.3 | 0.4 | ||||||||||
balance-sheet.row.total-current-assets | 197.6 | 52.3 | 31.7 | 24 | ||||||||||
balance-sheet.row.property-plant-equipment-net | 3.82 | 1 | 0.1 | 0.4 | ||||||||||
balance-sheet.row.goodwill | 36.23 | 9.1 | 0.9 | 0.3 | ||||||||||
balance-sheet.row.intangible-assets | 87.71 | 21.8 | 7.4 | 0.5 | ||||||||||
balance-sheet.row.goodwill-and-intangible-assets | 123.94 | 30.9 | 8.3 | 0.5 | ||||||||||
balance-sheet.row.long-term-investments | 39.56 | 13.1 | 18.8 | 6.2 | ||||||||||
balance-sheet.row.tax-assets | 0.85 | 0.4 | 0 | 0 | ||||||||||
balance-sheet.row.other-non-current-assets | -83.66 | 0 | 0.8 | 1.2 | ||||||||||
balance-sheet.row.total-non-current-assets | 168.18 | 45.4 | 28.1 | 8.3 | ||||||||||
balance-sheet.row.other-assets | 0.85 | 0 | 0 | 0 | ||||||||||
balance-sheet.row.total-assets | 366.64 | 97.7 | 59.7 | 32.3 | ||||||||||
balance-sheet.row.account-payables | 78.02 | 20.4 | 0.7 | 0.1 | ||||||||||
balance-sheet.row.short-term-debt | 14.76 | 6.7 | 0.9 | 0.1 | ||||||||||
balance-sheet.row.tax-payables | 0 | 0 | 0 | 0 | ||||||||||
balance-sheet.row.long-term-debt-total | 12.98 | 3.4 | 0.7 | 0 | ||||||||||
Deferred Revenue Non Current | 0 | 0 | 0 | 2.6 | ||||||||||
balance-sheet.row.deferred-tax-liabilities-non-current | 3.56 | - | - | - | ||||||||||
balance-sheet.row.other-current-liab | 49.74 | 10.4 | 4.9 | 3.2 | ||||||||||
balance-sheet.row.total-non-current-liabilities | 16.68 | 5.3 | 1.7 | 2.6 | ||||||||||
balance-sheet.row.other-liabilities | 4.67 | 0 | 0 | 0 | ||||||||||
balance-sheet.row.capital-lease-obligations | 1.25 | 0.6 | 0 | 0.1 | ||||||||||
balance-sheet.row.total-liab | 168.36 | 43 | 8.3 | 6.1 | ||||||||||
balance-sheet.row.preferred-stock | 0 | 0 | 0 | 0 | ||||||||||
balance-sheet.row.common-stock | 0 | 0 | 0 | 93 | ||||||||||
balance-sheet.row.retained-earnings | -358.74 | -85.6 | -74.2 | -81 | ||||||||||
balance-sheet.row.accumulated-other-comprehensive-income-loss | 26.97 | 13.2 | 12.6 | 10.7 | ||||||||||
balance-sheet.row.other-total-stockholders-equity | 473.58 | 111.5 | 110.8 | 0.2 | ||||||||||
balance-sheet.row.total-stockholders-equity | 141.81 | 39.1 | 49.2 | 23 | ||||||||||
balance-sheet.row.total-liabilities-and-stockholders-equity | 183.32 | 97.7 | 59.7 | 32.3 | ||||||||||
balance-sheet.row.minority-interest | 56.46 | 15.5 | 2.2 | 3.2 | ||||||||||
balance-sheet.row.total-equity | 198.27 | 54.7 | 51.4 | 26.2 | ||||||||||
balance-sheet.row.total-liabilities-and-total-equity | 183.32 | - | - | - | ||||||||||
Total Investments | 47.67 | 18.1 | 22.2 | 6.2 | ||||||||||
balance-sheet.row.total-debt | 21.73 | 10.1 | 1.6 | 0.1 | ||||||||||
balance-sheet.row.net-debt | -43.12 | -9.9 | -22.4 | -22.3 |
Kapitalflussrechnung
common:word.in-mln USD Growth | TTM | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
cash-flows.row.net-income | -21.79 | -10.1 | 4.2 | -6.8 | |||||||||||
cash-flows.row.depreciation-and-amortization | 5.1 | 3.2 | 0.3 | 0.2 | |||||||||||
cash-flows.row.deferred-income-tax | -5.51 | 0.4 | -12.8 | -1.1 | |||||||||||
cash-flows.row.stock-based-compensation | 0.63 | 0.8 | 2.4 | 1.4 | |||||||||||
cash-flows.row.change-in-working-capital | -2.08 | -1.1 | 0.1 | -0.3 | |||||||||||
cash-flows.row.account-receivables | -3.62 | -7.8 | -0.2 | -0.1 | |||||||||||
cash-flows.row.inventory | -1.09 | -0.6 | -0.6 | -0.5 | |||||||||||
cash-flows.row.account-payables | 3.64 | 5.8 | 1 | 0.1 | |||||||||||
cash-flows.row.other-working-capital | -1.01 | 1.4 | -0.1 | 0.2 | |||||||||||
cash-flows.row.other-non-cash-items | 14.17 | 1.2 | 0.6 | 0.5 | |||||||||||
cash-flows.row.net-cash-provided-by-operating-activities | -9.5 | 0 | 0 | 0 | |||||||||||
cash-flows.row.investments-in-property-plant-an-equipment | -1.8 | -0.1 | -0.1 | -0.3 | |||||||||||
cash-flows.row.acquisitions-net | -2.92 | -2.4 | -7.7 | -1.3 | |||||||||||
cash-flows.row.purchases-of-investments | -2.86 | -6.6 | -0.2 | -1.8 | |||||||||||
cash-flows.row.sales-maturities-of-investments | 1.24 | 0.5 | 1.9 | 3.1 | |||||||||||
cash-flows.row.other-investing-activites | -5.45 | 4.1 | -6.2 | -1.3 | |||||||||||
cash-flows.row.net-cash-used-for-investing-activites | -11.79 | -4.5 | -12.4 | -1.6 | |||||||||||
cash-flows.row.debt-repayment | -3.32 | -4.7 | -1.5 | 0 | |||||||||||
cash-flows.row.common-stock-issued | 13.25 | 12.6 | 18.7 | 23 | |||||||||||
cash-flows.row.common-stock-repurchased | -2.38 | 0 | 0 | -22.9 | |||||||||||
cash-flows.row.dividends-paid | -7.11 | -4.2 | 0 | -0.1 | |||||||||||
cash-flows.row.other-financing-activites | 1.72 | 1.8 | 1.9 | 0.1 | |||||||||||
cash-flows.row.net-cash-used-provided-by-financing-activities | 5.18 | 5.4 | 19.1 | 22.9 | |||||||||||
cash-flows.row.effect-of-forex-changes-on-cash | 0.88 | 0.8 | 0.2 | 0.1 | |||||||||||
cash-flows.row.net-change-in-cash | -14.71 | -4 | 1.7 | 15.3 | |||||||||||
cash-flows.row.cash-at-end-of-period | 50.04 | 20.1 | 24 | 22.4 | |||||||||||
cash-flows.row.cash-at-beginning-of-period | 64.75 | 24 | 22.4 | 7 | |||||||||||
cash-flows.row.operating-cash-flow | -9.5 | -5.7 | -5.3 | -6.1 | |||||||||||
cash-flows.row.capital-expenditure | -1.8 | -0.1 | -0.1 | -0.3 | |||||||||||
cash-flows.row.free-cash-flow | -11.29 | -5.7 | -5.4 | -6.5 |
Zeile der Gewinn- und Verlustrechnung
common:word.in-mln USD Growth | TTM | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
income-statement-row.row.total-revenue | 166.86 | 91.9 | 10.1 | 0.5 | |||||||||||
income-statement-row.row.cost-of-revenue | 141.96 | 77.4 | 5.3 | 1 | |||||||||||
income-statement-row.row.gross-profit | 24.9 | 14.5 | 4.8 | -0.5 | |||||||||||
income-statement-row.row.gross-profit-ratio | 0 | 0 | 0 | 0 | |||||||||||
income-statement-row.row.research-development | 8.23 | - | - | - | |||||||||||
income-statement-row.row.selling-general-administrative | 16.81 | - | - | - | |||||||||||
income-statement-row.row.selling-and-marketing-expenses | 3.76 | - | - | - | |||||||||||
income-statement-row.row.other-expenses | 0 | 0 | 0.5 | 0 | |||||||||||
income-statement-row.row.operating-expenses | 40.69 | 23 | 13 | 7 | |||||||||||
income-statement-row.row.cost-and-expenses | 182.65 | 100.4 | 18.3 | 8 | |||||||||||
income-statement-row.row.interest-income | 2.49 | 2.3 | 0.3 | 0.2 | |||||||||||
income-statement-row.row.interest-expense | 2.53 | -4.1 | 0.3 | 0 | |||||||||||
income-statement-row.row.selling-and-marketing-expenses | 3.76 | - | - | - | |||||||||||
income-statement-row.row.total-other-income-expensenet | -5.75 | 3.7 | 12.3 | 0.5 | |||||||||||
income-statement-row.row.ebitda-ratio-caps | 0 | - | - | - | |||||||||||
income-statement-row.row.other-operating-expenses | 0 | 0 | 0.5 | 0 | |||||||||||
income-statement-row.row.total-operating-expenses | -5.75 | 3.7 | 12.3 | 0.5 | |||||||||||
income-statement-row.row.interest-expense | 2.53 | -4.1 | 0.3 | 0 | |||||||||||
income-statement-row.row.depreciation-and-amortization | 5.1 | 1.8 | -14 | -0.5 | |||||||||||
income-statement-row.row.ebitda-caps | -9.36 | - | - | - | |||||||||||
income-statement-row.row.operating-income | -14.45 | -13.8 | -8.2 | -7.4 | |||||||||||
income-statement-row.row.income-before-tax | -20.2 | -10.1 | 4.2 | -6.8 | |||||||||||
income-statement-row.row.income-tax-expense | 0.42 | 0.1 | 0.1 | 0 | |||||||||||
income-statement-row.row.net-income | -21.79 | -10.2 | 4 | -6.8 |
Häufig gestellte Frage
Wie hoch ist die Medigus Ltd. (MDGS) Gesamtvermögen?
Medigus Ltd. (MDGS) Gesamtvermögen ist 97651000.000.
Wie hoch ist der Jahresumsatz des Unternehmens?
Der Jahresumsatz ist 80077500.000.
Wie hoch ist die Gewinnspanne des Unternehmens?
Die Gewinnmarge des Unternehmens ist 0.150.
Wie hoch ist der freie Cashflow des Unternehmens?
Der freie Cashflow ist -5.754.
Wie hoch ist die Nettogewinnspanne des Unternehmens?
Die Nettogewinnmarge ist -0.135.
Wie hoch sind die Gesamteinnahmen des Unternehmens?
Der Gesamtertrag ist -0.086.
Was ist der Medigus Ltd. (MDGS) nettogewinn (reingewinn)?
Der Nettogewinn (Nettoeinkommen) ist -10208000.000.
Wie hoch ist die Gesamtverschuldung des Unternehmens?
Die Gesamtverschuldung ist 10135000.000.
Wie hoch ist der Betriebsaufwand?
Die Betriebsausgaben sind 23033000.000.
Wie hoch ist der Bargeldbestand des Unternehmens?
Die Unternehmensliquidität ist 12359000.000.